Elysium Health and Long-Term Healthy Living

There is a vast supplement market fueled by health-conscious people seeking the nutrition needed to live healthier and longer lives. The myriad of options and the impossibility of taking all of them at once create substantial confusion about how to prioritize what is really helpful. Ads pushing unverified claims hardly clarify anything.

Elysium Health appears to offer promise for an oasis in this desert. The credibility of any business starts with the quality of its leadership and staff. Consumer health company Elysium Health was co-founded by an MIT scientist and has on its advisory board more than two dozen renowned scientists and clinicians from the world’s leading academic institutions. They guide the direction of the company and its research.

According to their website, “Elysium’s mission is to solve the biggest challenges in health with science , to help people live healthier, longer. Specifically, their goal is to take the findings from scientific research and translate them into health products that work.

Elysium Health points out that “cellular health is the foundation of overall health.” A coenzyme known as NAD+ (nicotinamide adenine dinucleotide) is critical to cellular health. Cells need proteins called sirtuins to maintain homeostasis under stress, and they cannot function without NAD+. NAD+ is essential for hundreds of biological processes including turning nutrients into energy, maintaining the health of DNA, and regulating circadian rhythms. .

As we age, we have less NAD+ in our cells, and this appears to explain a lot about why the aforementioned functions decline. Elysium’s first product, Basis, is designed to support cellular health and clinically proven to increase levels of NAD+.

Elysium’s clinical trial demonstrated that Basis safely increased NAD+ levels in humans by an average of 40 percent within four weeks. The increase was sustained for the duration of the trial.

Basis contains the  active ingredients nicotinamide riboside and pterostilbene.

The ingredients in Basis have been tested for safety and are produced in facilities that meet FDA requirements. No animal products are used in Basis. Basis also undergoes rigorous third party purity testing.

Elysium’s website sells Basis in bottles containing 60 capsules, a one-month supply. The recommended dosage is two capsules each morning. Pricing range from $40 per bottle for a one-year subscription ($480) with monthly delivery to $60 for an individual bottle.

https://www.elysiumhealth.com/

Clay Siegall Has Done His Best Genetic Work With Seattle Genetics

Seattle Genetics is a medication manufacturer that was founded by Clay Siegall for his antibody based medications. He wanted to create a new type of drug that he believed would have a higher rate of success, and he also wanted to to learn how many different types of cancer he could attack. His genetics research goes on to their day, and company is now so strong that they might start doing even more than they originally intended.

The medications that were first created at Seattle Genetics cover only two types of cancer, and now Clay Siegall believes that his company could create as many 12 drugs to help combat different types of cancer. The genetics work that is being done by the company could potentially treat people with a wide range of cancers, and that means that all these people will be able to have some kind of medication that works for them.

The company has done a lot of sales in the last year, and they are now ready to begin work on drugs that they once thought they could not do. The possibilities are endless, and Seattle Genetics could potentially multiply their output by many times. It is very important for every cancer patient to keep their eye on this company as it works.

Clay Siegall has created an environment where his company will be able to raise the money for more new drugs, and they have the solid research foundation in place. Clay Siegall can do the groundbreaking work that he does, and the company will prosper. In the midst of all that, cancer patients can be treated for many conditions.

Learn more about Clay Siegall:

https://www.crunchbase.com/person/clay-b-siegall#/entity

http://www.bloomberg.com/research/stocks/people/person.asp?personId=607509&privcapId=34145